Nextech Invest Ltd.
An institutional investment manager in Zurich. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1595430.
- Reported value$2.11bn
- Positions15
Holdings: 15 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 16 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Revolution Medicines IncRVMD | COM | 76155X100 | 1,424 | 67.6% | 7,601,087 | Unchanged | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 128 | 6.1% | 4,663,176 | New+4,663,176 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 127 | 6.0% | 6,776,506 | Added+1,250,000 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 114 | 5.4% | 3,553,585 | Reduced−502,276 | |
| Alumis IncALMS | COM | 022307102 | 99.6 | 4.7% | 3,540,998 | Unchanged | |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 77.6 | 3.7% | 7,162,637 | Unchanged | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 32.0 | 1.5% | 278,896 | Unchanged | |
| Zymeworks IncZYME | COM | 98985Y108 | 29.1 | 1.4% | 1,113,946 | Unchanged | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 18.4 | 0.9% | 761,153 | Added+456,916 | |
| Arvinas IncARVN | COM | 04335A105 | 17.1 | 0.8% | 1,122,713 | Added+583,319 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 16.7 | 0.8% | 4,449,932 | Unchanged | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 10.5 | 0.5% | 952,400 | Unchanged | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 6.7 | 0.3% | 450,000 | Unchanged | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 4.1 | 0.2% | 7,419,355 | Unchanged | |
| Engene Therapeutics IncENGN | COM | 29286X101 | 4.0 | 0.2% | 2,324,943 | New+2,324,943 |
Sold out: 4 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 0.0 | 0.0% | 0 | Sold out−610,703 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 0.0 | 0.0% | 0 | Sold out−1,141,145 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−2,324,943 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 0.0 | 0.0% | 0 | Sold out−7,266,081 |
Source: SEC EDGAR, Form 13F-HR, accession 0001595430-26-000010 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.